Washington Post
In a head-to-head comparison of two immunotherapy drugs used to prevent relapse in certain patients with advanced melanoma, one treatment was the clear winner — and it’s not the one that most people get. The international study, released Sunday, …
After melanoma surgery, Bristol’s Opdivo offers new care standardReuters
Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancerEndpoints News

all 6 news articles …read more

Source: HEALTH